Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/23/10 → 2/29/12 |
Phase 2, Open-Label, Controlled Randomized Study of CDX-1307 Vaccine Regimen as Neoadjuvant & Adjuvant Therapy in Patients with Newly Diagnosed Muscle-Invasive Bladder Cancer Expressing hCG-B
- Crispen, Paul (PI)